Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 ...
The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...
Accuracy is the make-or-break factor. If a detector flags too much code by mistake, it wastes time and frustrates developers. If it misses AI-generated sections, it cannot deliver the transparency ...
Pacific Empire Minerals Corp. , a copper-gold explorer based in , is pleased to provide shareholders with a year-end corporate update summarizing key milestones achieved during 2025 and outlining its ...
DuckDB has recently introduced end-to-end interaction with Iceberg REST Catalogs directly within a browser tab, requiring no ...
The first ThreatsDay Bulletin of 2026 tracks GhostAd adware, macOS malware, proxy botnets, cloud exploits, and more emerging ...
Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...
Lavras Gold Corp. (TSXV: LGC) (OTCQX: LGCFF) (“Lavras Gold” or the “Company”) is pleased to announce new assay results from its ongoing ...
In the first year of the Poynter Journalism Prizes, judges named winners and finalists in 10 categories in April 2024. They ...
An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback